Romulus Brazzell
Chief Tech/Sci/R&D Officer bij KALA BIO, INC.
Vermogen: 37 594 $ op 31-03-2024
Profiel
Romulus Kim Brazzell is currently the Director at Mimetogen Pharmaceuticals, Inc. since 2024 and the Chief Medical Officer, Head-Research & Development at KALA BIO, Inc. since 2013.
Previously, he held positions such as Associate Director-Research & Development at Alcon Laboratories, Inc. from 1990 to 1991, Executive VP-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc. from 2010 to 2011, Senior Vice President-US Research & Development at Novartis Ophthalmics, Inc. from 2000 to 2004, Chief Medical Officer at Mimetogen Pharmaceuticals, Inc. from 2012 to 2015, Vice President-Research & Development at Ciba Vision Ophthalmics Co. from 1996 to 2000, and Principal at Acuity Advisors LLC from 2014 to 2018.
Dr. Brazzell obtained his undergraduate and doctorate degrees from the University of Kentucky.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KALA BIO, INC.
0.18% | 04-01-2024 | 4 717 ( 0.18% ) | 37 594 $ | 31-03-2024 |
Actieve functies van Romulus Brazzell
| Bedrijven | Functie | Begin |
|---|---|---|
| KALA BIO, INC. | Chief Tech/Sci/R&D Officer | 01-02-2013 |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Director/Board Member | 01-01-2024 |
Eerdere bekende functies van Romulus Brazzell
| Bedrijven | Functie | Einde |
|---|---|---|
Acuity Advisors LLC
 Acuity Advisors LLC Investment ManagersFinance Acuity Advisors LLC is a private company that provides brand strategy, digital experience, custom applications, solution management, design, brand identity, user experience, information design, print design, and technology development services. The company is based in Woodstock, GA. The company helps their clients create their digital strategy and turn it into action through digital experience, storytelling, intelligent technology, and results measured down to each user. | Corporate Officer/Principal | 01-07-2018 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Chief Tech/Sci/R&D Officer | 01-12-2015 |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Chief Tech/Sci/R&D Officer | 01-01-2011 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Chief Tech/Sci/R&D Officer | 01-01-2004 |
| Ciba Vision Ophthalmics Co. | Chief Tech/Sci/R&D Officer | 01-01-2000 |
Opleiding van Romulus Brazzell
| University of Kentucky | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
| Ciba Vision Ophthalmics Co. | |
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Acuity Advisors LLC is a private company that provides brand strategy, digital experience, custom applications, solution management, design, brand identity, user experience, information design, print design, and technology development services. The company is based in Woodstock, GA. The company helps their clients create their digital strategy and turn it into action through digital experience, storytelling, intelligent technology, and results measured down to each user. | Finance |
